| Trial ID: | L4053 |
| Source ID: | NCT05333835
|
| Associated Drug: |
Hr17031 Injection
|
| Title: |
A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: HR17031 injection|DRUG: INS068 injection|DRUG: SHR20004 injection
|
| Outcome Measures: |
Primary: Mean Change From Baseline in HbA1c at Week 26, at Week 26 | Secondary: Mean Change From Baseline in fasting plasma glucose (FPG) at Week 26, at Week 26|Mean Change From Baseline in Body Weight at Week 26, at Week 26|Proportion of subjects reaching HbA1c targets (<7.0%; ≤6.5%) at Week 26, at Week 26|Mean Actual Daily Insulin Dose at Week 26, at Week 26|Number of Hypoglycaemic Episodes at Week 26, at Week 26
|
| Sponsor/Collaborators: |
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
455
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-07-08
|
| Completion Date: |
2024-03-30
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-25
|
| Locations: |
Peking university People's Hospital, Beijing, Beijing, 100044, China
|
| URL: |
https://clinicaltrials.gov/show/NCT05333835
|
